Caladrius Biosciences, Inc.
(NASDAQ : CLBS)

( )
CLBS After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Distribution Services » Wholesale Distributors
symbolcompany%chnglast%shortavg$volume
GWWW.W. Grainger, Inc.
-1.76%161.5311.3%$132.31m
FASTFastenal Company
-0.58%41.166.9%$114.72m
HDSHD Supply Holdings, Inc.
-0.93%30.781.6%$86.94m
GPCGenuine Parts Company
-0.07%82.581.8%$70.59m
MSMMSC Industrial Direct Co., Inc. Class A
-0.25%67.014.0%$41.80m
POOLPool Corporation
-2.28%103.822.1%$30.88m
WCCWESCO International, Inc.
-0.85%49.832.8%$24.67m
UNVRUnivar, Inc.
0.32%27.851.4%$24.55m
BECNBeacon Roofing Supply, Inc.
-1.78%39.642.8%$19.55m
INTWorld Fuel Services Corporation
0.21%33.333.5%$17.26m
DNOWNOW Inc
1.80%11.906.1%$16.48m
MRCMRC Global Inc.
0.45%15.645.0%$15.36m
AITApplied Industrial Technologies, Inc.
0.37%54.901.2%$12.95m
SUNSunoco LP
1.35%31.193.5%$12.68m
CORECore-Mark Holding Company, Inc.
-1.43%27.556.0%$8.97m

Company Profile

Caladrius Biosciences, Inc. operates as a global healthcare company, which engages in developing cellular therapies that repair damaged tissue, cells and organs and restore their normal function. It is pursuing the preservation and enhancement of human health globally through the development of cell based therapeutics that prevent, treat or cure disease. Its business includes the development of novel proprietary cell therapy products, as well as a revenue-generating contract development and manufacturing service business that it leverages for the development of therapeutics while providing service to other companies in the cell therapy industry developing products. The company was founded in September 1980 and is headquartered in New York, NY.